The novel treatment of this peptide represents a exciting development in the management of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects dual pathways – GLP-1 and GIP – leading to https://tirzepatide-peptide305421.goabroadblog.com/40727351/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment